Lamivudine And Zidovudine Tablet
Product Images NDC 33342-003

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 33342-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12x10s (Lamizido 12x10s)

This is a pharmaceutical product called "Lamivudine and Zidovudine Tablets, USP" manufactured by Macleods Pharmaceuticals Ltd. in Daman, India for Macleods Pharma USA, Inc. in Plainsboro, NJ. The tablets come in a package of 120 tablets, each containing 150 mg of lamivudine and 300 mg of zidovudine. It provides information about storing the tablets at a temperature range of 20° to 25°C, dosage information, and a cautionary note that the package is not child-resistant.*

FDA Label Image

Lami (Lamizido 60s Container)

This is a description of a medication called udine USP available in two strengths, 150 mg and 300 mg (NDC 33342003-00 Zidovudine). The usual dosage and administration information for Lamiivudine and Zidovudine tablets USP are available in the prescribing information. The medication should be stored at a temperature range of 15° to 30°C (59° to 86°F), with excursions permitted up to 150mg/300mg at 20° to 25°C (68° to 77°F). The medication is manufactured by Macleods Pharmaceuticals Ltd for Macleods Pharma USA, Inc., and each bottle contains 60 tablets.*

FDA Label Image

6x10s (Lamizido 6x10s)

Lamivudine and Zidovudine tablets, manufactured by Macleods Pharmaceuticals Ltd in India, are available in a 60 unit dose package with each tablet containing 150 mg of Lamivudine and 300 mg of Zidovudine. This medication is used for treating HIV. It is important to follow the prescribing information for Dosage and Administration as this unit-dose package is not-child resistant. The expiration date and batch number are provided, and the tablets should be stored between 20° to 25°C.*

FDA Label Image

Lami (Lamizido Lamivudine)

FDA Label Image

Zido (Lamizido Zidovudine)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.